NL8005577A - Werkwijze voor het bereiden van een vaccin. - Google Patents
Werkwijze voor het bereiden van een vaccin. Download PDFInfo
- Publication number
- NL8005577A NL8005577A NL8005577A NL8005577A NL8005577A NL 8005577 A NL8005577 A NL 8005577A NL 8005577 A NL8005577 A NL 8005577A NL 8005577 A NL8005577 A NL 8005577A NL 8005577 A NL8005577 A NL 8005577A
- Authority
- NL
- Netherlands
- Prior art keywords
- vaccine
- virus
- poultry
- genus
- vgnki
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims description 96
- 238000000034 method Methods 0.000 title claims description 30
- 241000700605 Viruses Species 0.000 claims description 59
- 241000287828 Gallus gallus Species 0.000 claims description 46
- 201000010099 disease Diseases 0.000 claims description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 24
- 238000002360 preparation method Methods 0.000 claims description 22
- 241000271566 Aves Species 0.000 claims description 16
- 210000002257 embryonic structure Anatomy 0.000 claims description 14
- 230000004071 biological effect Effects 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 11
- 241000711404 Avian avulavirus 1 Species 0.000 claims description 10
- 230000001681 protective effect Effects 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 6
- 210000001161 mammalian embryo Anatomy 0.000 claims description 6
- 238000009395 breeding Methods 0.000 claims description 4
- 230000001488 breeding effect Effects 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 208000011090 bird disease Diseases 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims 1
- 244000144977 poultry Species 0.000 description 47
- 235000013594 poultry meat Nutrition 0.000 description 47
- 235000013330 chicken meat Nutrition 0.000 description 44
- 241001465754 Metazoa Species 0.000 description 27
- 238000002255 vaccination Methods 0.000 description 23
- 210000001331 nose Anatomy 0.000 description 17
- 238000010790 dilution Methods 0.000 description 13
- 239000012895 dilution Substances 0.000 description 13
- 208000015181 infectious disease Diseases 0.000 description 12
- 210000004400 mucous membrane Anatomy 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 230000036039 immunity Effects 0.000 description 9
- 230000003053 immunization Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 235000012206 bottled water Nutrition 0.000 description 7
- 239000003651 drinking water Substances 0.000 description 7
- 238000002649 immunization Methods 0.000 description 7
- 230000005847 immunogenicity Effects 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000010359 Newcastle Disease Diseases 0.000 description 6
- 239000000443 aerosol Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000002163 immunogen Effects 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 4
- 210000002845 virion Anatomy 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000035931 haemagglutination Effects 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000011321 prophylaxis Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 208000027954 Poultry disease Diseases 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 238000001856 aerosol method Methods 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000012770 revaccination Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 101000576973 Homo sapiens Mitochondrial-processing peptidase subunit beta Proteins 0.000 description 1
- 244000116484 Inula helenium Species 0.000 description 1
- 102100025298 Mitochondrial-processing peptidase subunit beta Human genes 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU792833299A SU826584A1 (ru) | 1979-10-29 | 1979-10-29 | Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц |
| SU2833299 | 1979-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8005577A true NL8005577A (nl) | 1981-06-01 |
Family
ID=20856462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8005577A NL8005577A (nl) | 1979-10-29 | 1980-10-09 | Werkwijze voor het bereiden van een vaccin. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4279893A (da) |
| CA (1) | CA1159366A (da) |
| DE (1) | DE3034238A1 (da) |
| DK (1) | DK453880A (da) |
| GB (1) | GB2062461B (da) |
| NL (1) | NL8005577A (da) |
| SU (1) | SU826584A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ224567A (en) * | 1987-05-19 | 1990-08-28 | Yissum Res Dev Co | Vaccine against newcastle disease virus comprising a live immunogenic lentogenic or mesogenic strain of newcastle disease virus in combination with a liquid containing a mineral or vegetable oil |
| ES2060740T3 (es) * | 1988-07-18 | 1994-12-01 | Duphar Int Res | Vacunas de virus vivos para la enfermedad de newcastle. |
| US5118502A (en) * | 1989-06-20 | 1992-06-02 | The University Of Georgia Research Foundation, Inc. | Naturally attenuated newcastle disease vaccine and method of using the same |
| US5427791A (en) * | 1992-08-05 | 1995-06-27 | Regents Of The University Of Minnesota | Embryonal vaccine against Newcastle disease |
| US5753228A (en) * | 1992-08-25 | 1998-05-19 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies |
| CA2181862C (en) * | 1995-08-01 | 2009-12-22 | Carla Christina Schrier | Mild newcastle disease virus vaccine |
| IL139538A0 (en) * | 1998-05-15 | 2004-02-08 | Mkb Invest Ltd Partnership | Compositions and method for immunizing poultry |
| US6517844B1 (en) | 1999-05-14 | 2003-02-11 | Marshall K. Brinton | Compositions and method for immunizing polutry |
| RU2378013C1 (ru) * | 2008-09-26 | 2010-01-10 | ГНУ ВНИИ ветеринарной вирусологии и микробиологии | Способ изготовления вирусвакцины против ньюкаслской болезни птиц для орального применения |
| KR101258619B1 (ko) * | 2010-07-12 | 2013-04-29 | 대한민국 | 새로운 약독형 유전아형의 뉴캣슬병 바이러스 백신주 및 이를 포함하는 뉴캣슬병 바이러스 백신 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2767117A (en) * | 1953-10-22 | 1956-10-16 | Crawley John Frederick | Poultry virus vaccine products and method of preparing the same |
| US2798835A (en) * | 1954-01-18 | 1957-07-09 | American Cyanamid Co | Newcastle disease and infectious bronchitis vaccines and production thereof |
| US3060094A (en) * | 1959-04-07 | 1962-10-23 | Ray M Dutcher | Preparation of virus vaccines |
| US3029190A (en) * | 1959-08-04 | 1962-04-10 | Hanson Robert Paul | Selection of neurotropic viral strains and preparation of vaccines therefrom |
| GB1010509A (en) * | 1962-02-23 | 1965-11-17 | Pfizer Ltd | Improvements in or relating to newcastle disease virus vaccines |
| DE1617457A1 (de) * | 1966-12-16 | 1972-04-20 | Erba Carlo Spa | Verfahren zur Stabilisierung von Zubereitungen interferierender Virusprodukte |
| US3548054A (en) * | 1969-06-06 | 1970-12-15 | Lilly Co Eli | Method for improving weight gains and reducing gross lesions in chickens exposed to marek's disease |
| DK124340B (da) * | 1969-11-29 | 1972-10-09 | Takeda Chemical Industries Ltd | Fremgangsmåde til fremstilling af stærk svækket, levende Newcastle-syge-virus-vaccine. |
| US3876763A (en) * | 1970-12-29 | 1975-04-08 | Shionogi & Co | Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof |
| US4071618A (en) * | 1974-09-03 | 1978-01-31 | Research Foundation For Microbial Diseases Of Osaka University | Process for preparing virus disease live vaccines |
| US4053583A (en) * | 1976-03-01 | 1977-10-11 | Smithkline Corporation | Live newcastle disease virus vaccines |
| BE853923A (fr) * | 1977-04-25 | 1977-10-25 | Rit Rech Ind Therapeut | Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation |
| EP0009277B1 (en) * | 1978-09-14 | 1984-04-18 | Gist-Brocades N.V. | Combined vaccine active against newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and newcastle disease virus strains |
-
1979
- 1979-10-29 SU SU792833299A patent/SU826584A1/ru active
-
1980
- 1980-09-08 US US06/184,933 patent/US4279893A/en not_active Expired - Lifetime
- 1980-09-11 DE DE19803034238 patent/DE3034238A1/de not_active Ceased
- 1980-10-03 GB GB8031930A patent/GB2062461B/en not_active Expired
- 1980-10-07 CA CA000361692A patent/CA1159366A/en not_active Expired
- 1980-10-09 NL NL8005577A patent/NL8005577A/nl not_active Application Discontinuation
- 1980-10-27 DK DK453880A patent/DK453880A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK453880A (da) | 1981-04-30 |
| SU826584A1 (ru) | 1982-11-07 |
| GB2062461B (en) | 1983-10-19 |
| US4279893A (en) | 1981-07-21 |
| GB2062461A (en) | 1981-05-28 |
| CA1159366A (en) | 1983-12-27 |
| DE3034238A1 (de) | 1981-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4530831A (en) | Infectious Bursal Disease vaccine | |
| Vakharia et al. | Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins | |
| US4224412A (en) | Living virus culture vaccine against canine distemper and method of preparing same | |
| JP7354106B2 (ja) | レプリコン粒子および油性アジュバントによるワクチン接種 | |
| IE53872B1 (en) | Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain | |
| US4751079A (en) | Infectious bronchitis vaccines | |
| NO153010B (no) | Fremgngsmaate for fremstilling av vaksine mot newcastle-sykdom i fjaerkre | |
| US4302444A (en) | Vaccines for immunizing egg-laying birds against Egg Drop disease, preparation of said vaccines, and method of use of said vaccines | |
| NL8005577A (nl) | Werkwijze voor het bereiden van een vaccin. | |
| US4320115A (en) | Rabies virus vaccine | |
| JP3945842B2 (ja) | 弱毒性ニューカッスル病ウイルスワクチン | |
| CZ282443B6 (cs) | Očkovací látka pro prevenci infekční bursitidy u drůbeže a způsob její výroby | |
| Mazija et al. | Immunogenicity and safety of Queensland V4 and Ulster 2C strains of Newcastle disease virus given to maternally immune, newly hatched chickens by nebulization | |
| Crick | The vaccination of man and other animals against rabies | |
| RU2127603C1 (ru) | Инактивированная вакцина против инфекционной бурсальной болезни птиц | |
| RU2323741C2 (ru) | Вакцина против гриппа птиц инактивированная эмульсионная | |
| RU2233671C1 (ru) | Инактивированная вакцина против синдрома снижения яйценоскости-76 птиц | |
| JPS6244528B2 (da) | ||
| RU2239452C2 (ru) | Способ изготовления инактивированной вакцины против синдрома снижения яйценоскости-76 птиц | |
| RU2283136C2 (ru) | Инактивированная сорбированная вакцина против инфекционной бурсальной болезни птиц | |
| KR810001063B1 (ko) | 생 뉴캣슬(Newcastle)병 바이러스 백신의 제법 | |
| RU2283137C2 (ru) | Инактивированная эмульсионная вакцина против инфекционной бурсальной болезни птиц | |
| RU2236255C1 (ru) | Культуральная вирусвакцина против ньюкаслской болезни | |
| RU2193062C1 (ru) | Штамм кр 95 № 114 вируса синдрома гидроперикардита кур для изготовления вакцинных препаратов | |
| RU2221865C1 (ru) | Штамм "бисс № 113" вируса синдрома снижения яйценоскости - 76 птиц для изготовления вакцинных препаратов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1A | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| A85 | Still pending on 85-01-01 | ||
| BI | The patent application has been withdrawn |